Calamos Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-551,100
Closed -$2.16M – 652
2018
Q4
$2.16M Buy
551,100
+185,500
+51% +$792K 0.01% 527
2018
Q3
$1.67M Buy
+365,600
New +$1.74M 0.01% 549
2017
Q1
– Sell
-81,700
Closed -$401K – 615
2016
Q4
$401K Sell
81,700
-547,200
-87% -$2.95M ﹤0.01% 580
2016
Q3
$3.83M Buy
628,900
+393,900
+168% +$2.35M 0.03% 386
2016
Q2
$1.39M Hold
235,000
– – 0.01% 501
2016
Q1
$1.22M Hold
235,000
– – 0.01% 511
2015
Q4
$1.05M Hold
235,000
– – 0.01% 523
2015
Q3
$1.15M Hold
235,000
– – 0.01% 527
2015
Q2
$1.43M Hold
235,000
– – 0.01% 527
2015
Q1
$1.35M Hold
235,000
– – 0.01% 529
2014
Q4
$1.46M Hold
235,000
– – 0.01% 515
2014
Q3
$1.54M Hold
235,000
– – 0.01% 476
2014
Q2
$1.65M Buy
235,000
+49,950
+27% +$368K 0.01% 469
2014
Q1
$1.37M Sell
185,050
-258,150
-58% -$1.81M 0.01% 484
2013
Q4
$3.26M Buy
+443,200
New +$3.24M 0.02% 369

Other funds holding ABEV

Calamos Advisors's ABEV Position: Q1 2019 in Review

Calamos Advisors sold out of Ambev (ABEV) in Q1 2019, closing a stake of 551,100 shares — an estimated $2.16M sold.

Calamos Advisors first reported a position in ABEV in Q4 2013 and held it in 15 quarters. The position peaked at $3.83M in Q3 2016. 305 funds tracked by Wall St. Rank hold ABEV as of Q1 2019.

  • Calamos Advisors reported no remaining Ambev position as of Q1 2019 after selling out during the quarter.
  • Calamos Advisors sold 551,100 Ambev shares in Q1 2019, an estimated $2.16M.
  • Calamos Advisors first reported a position in Ambev in Q4 2013 and held it in 15 quarters.
  • Calamos Advisors's Ambev position peaked at $3.83M in Q3 2016.
  • 305 funds tracked by Wall St. Rank held Ambev as of Q1 2019.

Based on Calamos Advisors's 13F filing for Q1 2019, filed 12 Apr 2019.